Position in BLLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
New position
Shares Held
0
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Derivatives in BLLN
reported options exposure · as of Jun 30, 2026CallValue
$2,759,540
CallShares
23,000
PutValue
$1,091,818
PutShares
9,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $941,973,796 across 32 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
1,783,444 | $267,570,103 | |
| 2 | NTRA |
Natera, Inc.
|
926,986 | $251,630,349 | |
| 3 | ILMN |
Illumina, Inc.
|
372,628 | $65,519,180 | |
| 4 | ICLR |
Icon PLC
|
374,800 | $65,106,507 | |
| 5 | RVTY |
Revvity, Inc.
|
576,014 | $64,087,317 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
105,108 | $55,333,055 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
282,508 | $54,586,195 | |
| 8 | DHR |
Danaher Corp /De/
|
189,123 | $36,024,147 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,091,818 | 9,100 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $2,759,540 | 23,000 | Call | Defined | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||